DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20214295

Burden of breast cancer in Bangladesh-current and future and financing treatment with link to willingness to pay

Tasdidaa Shamsi

Abstract


Breast cancer is the most common cancer type among females worldwide affecting 1 in 8 women. As of 2015, breast cancer is still a leading cancer of women in Bangladesh. It has become a hidden burden which accounts for 69% death of women within the country. The rate grows up day to day due to unawareness of the people, lack of confidence about medical treatment, improper screening, maltreatment, and lack of motivation to go for institutional treatment and management. The treatment options for breast cancer are relatively very expensive. People may be willing to sacrifice overall health to channel resources towards high priority disease areas, such as cancer to improve overall life. It is highly appropriate now to link treatment fall out and finances to the patient population. This short communication adopts a descriptive approach. First, it looks at the prevalence of breast cancer in Bangladesh, how breast cancer can be managed, how treatment can be financed and willingness to pay by individuals. This article finds that the screening can be optimized as the treatment options for breast cancer are relatively very expensive in a low resourced country such as Bangladesh. Data should be disseminated among the concerned stakeholders including the women susceptible to breast cancer, the patients, the care-givers, doctors, other health-care workers and policy-makers for better management. Improving the cancer scenario overnight is not an easy task but policy makers may become interested and push this agenda forward, if the huge health impact and economic loss caused by cancer become evident to them.


Keywords


Breast cancer, Healthcare financing, Willingness to pay

Full Text:

PDF

References


Christensen H, Marck D. The efficacy of mindfulness-based stress reduction (MBSR) for decreasing anxiety and depression among breast cancer survivors. Sch Physician Assist Stud. 2017;16:613.

Forazy, M. A. R. (2015). Healthcare.

Story HL, Love RR, Salim R, Roberto AJ, Krieger JL, Ginsburg OM. Improving outcomes from breast cancer in a low-income country: lessons from Bangladesh. Int j breast cancer. 2012;423562:9.

Yilmaz D, Awad A, Evans E, Mubin S, Ullah MZ. P146, Study of breast cancer presentation and triple negative status in Bangladeshi women resident in the UK compared to those living in Bangladesh. Eur J Surgical Oncol. 2010;45(5):922.

World Health Organization. Bangladesh health system review. Manila: WHO Regional Office for the Western Pacific. 2015. Available at: https://apps.who.int/iris/bitstream/handle/10665/208214/9789290617051_eng.pdf?sequence=1&isAllowed=y. Accessed on 3 August 2021.

Directorate General of Health Services Ministry of Health and Family Welfare, National Cancer Control Strategy and Plan of Action 2009-15. Available at: https://dghs.gov.bd/licts_file/images/Strategy/2009_NationalCancerControlStrategy2009-15.pdf. Accessed on 3 August 2021.

Islam RM, Bell RJ, Billah B, Hossain MB, Davis SR. Awareness of breast cancer and barriers to breast screening uptake in Bangladesh: A population-based survey. Maturitas. 2016;84:68-74.

Blouin-Bougie J, Amara N, Bouchard K, Simard J, Dorval M. Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Qu├ębec (Canada). BMJ open. 2018;8(2):e016662.

Shah KK. Is willingness to pay higher for cancer prevention and treatment? J Cancer Policy. 2017;11:60-4.

Iwatani T, Hara F, Iwata H, Shien T, Hojo T, Sagara Y, Kondo N. Abstract OT3-13-01: Estimation of willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A). Jpn J Clin Oncol. 2020;51(3):498-503.

Hussain SMA. Comprehensive update on cancer scenario of Bangladesh. South Asian j cancer. 2013;2(4):279.